North America Precision Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Genetic Tests, Esoteric Tests, and Others), Application (Oncology, Cardiology, Respiratory Diseases, Immunology, and Others), and End User (Clinical Laboratories, Hospitals, Homecare, and Others) 

No. of Pages: 136    |    Report Code: BMIRE00026146    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Precision Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Precision Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Precision Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in chronic diseases and cancer rates
  • 5.1.2 Technological advancements in diagnostic tools
  • 5.1.3 Growing demand for personalized medicine
5.2 Market Opportunities
  • 5.2.1 Development of non-invasive diagnostic solutions
  • 5.2.2 Growth in point-of-care diagnostics
  • 5.2.3 Expansion of diagnostic services in rural areas
5.3 Future Trends
  • 5.3.1 Shift toward molecular diagnostics
  • 5.3.2 Integration of AI in diagnostic tools
  • 5.3.3 Growth in liquid biopsy technologies
5.4 Impact of Drivers and Restraints

6. North America Precision Diagnostics Market Regional Analysis

6.1 North America Precision Diagnostics Market Overview
6.2 North America Precision Diagnostics Market Revenue 2020-2028 (US$ Million)
6.3 North America Precision Diagnostics Market Forecast Analysis

7. North America Precision Diagnostics Market Analysis – by Type

7.1 Genetic Tests
  • 7.1.1 Overview
  • 7.1.2 Genetic Tests: North America Precision Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Esoteric Tests
  • 7.2.1 Overview
  • 7.2.2 Esoteric Tests: North America Precision Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Precision Diagnostics Market Analysis – by Application

8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Oncology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
  • 8.2.1 Overview
  • 8.2.2 Cardiology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Respiratory Diseases
  • 8.3.1 Overview
  • 8.3.2 Respiratory Diseases: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunology
  • 8.4.1 Overview
  • 8.4.2 Immunology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Precision Diagnostics Market Analysis – by End User

9.1 Clinical Laboratories
  • 9.1.1 Overview
  • 9.1.2 Immunology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Hospitals
  • 9.2.1 Overview
  • 9.2.2 Immunology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Homecare
  • 9.3.1 Overview
  • 9.3.2 Immunology: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Precision Diagnostics Market – North America Analysis

10.1 North America
  • 10.1.1 North America Precision Diagnostics Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Precision Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Precision Diagnostics Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Precision Diagnostics Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Precision Diagnostics Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Precision Diagnostics Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Precision Diagnostics Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Precision Diagnostics Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Precision Diagnostics Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Precision Diagnostics Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Precision Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Precision Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bayer AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Koninklijke Philips N.V.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Lantheus Medical Imaging, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novartis AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 QIAGEN
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Quest Diagnostics Incorporated
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Sanofi
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Siemens Healthineers AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Swiss Precision Diagnostics GmbH
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Precision Diagnostics Market

  1. Abbott
  2. Bayer AG
  3. Koninklijke Philips N.V.
  4. Lantheus Medical Imaging, Inc.
  5. Novartis AG
  6. QIAGEN
  7. Quest Diagnostics Incorporated
  8. Sanofi
  9. Siemens Healthineers AG
  10. Swiss Precision Diagnostics GmbH
north-america-precision-diagnostics-market